SMTL ID : 6e6z.1

Structure of Wild Type Human Transthyretin in Complex with Tafamidis

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.75 Å

Oligo State

homo-tetramer

Ligands

4 x 3MI: 2-(3,5-dichlorophenyl)-1,3-benzoxazole-6-carboxylic acid(Non-covalent)

3MI.1: 15 residues within 4Å: Chain A: K.6, L.8, A.99, L.101, S.108, T.109, T.110 Chain C: K.6, L.8, A.99, L.101, S.108, T.109, T.110 Ligands: 3MI.3 8 PLIP interactions: 5 interactions with chain A, 3 interactions with chain C Hydrophobic interactions: A:A.99, A:T.110, C:L.101 Hydrogen bonds: A:E.45 Salt bridges: A:K.6, C:K.6 pi-Cation interactions: A:K.6, C:K.6 3MI.2: 15 residues within 4Å: Chain B: K.6, L.8, A.99, L.101, S.108, T.109, T.110 Chain D: K.6, L.8, A.99, L.101, S.108, T.109, T.110 Ligands: 3MI.4 7 PLIP interactions: 4 interactions with chain B, 3 interactions with chain D Hydrophobic interactions: B:K.6, B:A.99, B:L.101, D:K.6, D:A.99 Salt bridges: B:K.6, D:K.6 3MI.3: 15 residues within 4Å: Chain A: K.6, L.8, A.99, L.101, S.108, T.109, T.110 Chain C: K.6, L.8, A.99, L.101, S.108, T.109, T.110 Ligands: 3MI.1 8 PLIP interactions: 5 interactions with chain C, 3 interactions with chain A Hydrophobic interactions: C:A.99, C:T.110, A:L.101 Hydrogen bonds: C:E.45 Salt bridges: C:K.6, A:K.6 pi-Cation interactions: C:K.6, A:K.6 3MI.4: 15 residues within 4Å: Chain B: K.6, L.8, A.99, L.101, S.108, T.109, T.110 Chain D: K.6, L.8, A.99, L.101, S.108, T.109, T.110 Ligands: 3MI.2 7 PLIP interactions: 3 interactions with chain B, 4 interactions with chain D Hydrophobic interactions: B:K.6, B:A.99, D:K.6, D:A.99, D:L.101 Salt bridges: B:K.6, D:K.6

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Saelices, L. et al., Structural Variants of Transthyretin. To Be Published

Release Date

2019-07-31

Peptides

Transthyretin: ABCD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
A

D
B

Transthyretin

Related Entries With Identical Sequence